F FANAPT ILOPERIDONE

Serial Number 77676945
606

Registration Progress

Application Filed
Feb 24, 2009
Under Examination
Sep 29, 2009
Approved for Publication
Jun 17, 2009
Published for Opposition
Jul 7, 2009
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: F FANAPT ILOPERIDONE
Previous Owner: Vanda Pharmaceuticals Inc.
Classes: 005

Trademark Image

F FANAPT ILOPERIDONE

Basic Information

Serial Number
77676945
Filing Date
February 24, 2009
Published for Opposition
July 7, 2009
Abandonment Date
April 30, 2012
Drawing Code
3000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Apr 30, 2012
Classes
005

Rights Holder

Vanda Pharmaceuticals Inc.

03
Address
9605 Medical Center Drive, Suite 300
Rockville, MD 20850

Ownership History

Vanda Pharmaceuticals Inc.

Original Applicant
03
Rockville, MD

Vanda Pharmaceuticals Inc.

Owner at Publication
03
Rockville, MD

Legal Representation

Attorney
Jayme M. Torelli

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

32 events
Date Code Type Description Documents
Apr 30, 2012 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Apr 30, 2012 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Sep 24, 2011 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED Loading...
Sep 23, 2011 EX4G S SOU EXTENSION 4 GRANTED Loading...
Sep 21, 2011 EXT4 S SOU EXTENSION 4 FILED Loading...
Sep 21, 2011 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 22, 2011 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED Loading...
Mar 20, 2011 EX3G S SOU EXTENSION 3 GRANTED Loading...
Mar 14, 2011 EXT3 S SOU EXTENSION 3 FILED Loading...
Mar 14, 2011 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 1, 2010 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED Loading...
Sep 30, 2010 EX2G S SOU EXTENSION 2 GRANTED Loading...
Sep 6, 2010 EXT2 S SOU EXTENSION 2 FILED Loading...
Sep 30, 2010 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Sep 6, 2010 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 19, 2010 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED Loading...
Mar 17, 2010 EX1G S SOU EXTENSION 1 GRANTED Loading...
Mar 17, 2010 EXT1 S SOU EXTENSION 1 FILED Loading...
Mar 17, 2010 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 29, 2009 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 7, 2009 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 17, 2009 NPUB O NOTICE OF PUBLICATION Loading...
Jun 3, 2009 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Jun 3, 2009 ALIE A ASSIGNED TO LIE Loading...
Jun 2, 2009 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 22, 2009 CNEA F EXAMINER'S AMENDMENT MAILED Loading...
May 22, 2009 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
May 22, 2009 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
May 15, 2009 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 28, 2009 MDSC O NOTICE OF DESIGN SEARCH CODE MAILED Loading...
Feb 27, 2009 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 27, 2009 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for use in the treatment of the central nervous system
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Design Mark
The mark consists of stylized text reading "Fanapt" above stylized text reading "iloperidone"; each below an approximately vertically rectangular shape with rounded corners which is bisected substantially horizontally by a stylized lower case letter "f".
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"ILOPERIDONE"